PHARMACIA & UPJOHN RESCRIPTOR 15.1% REBATE AVAILABLE TO AIDS DRUG ASSISTANCE PROGRAMS; CLINICAL ENDPOINT TRIALS OF COMBINATION WITH PROTEASES PLANNED
Executive Summary
Pharmacia & Upjohn is offering a 15.1% rebate of the average manufacturer's price of Rescriptor (delavirdine) to AIDS drug assistance programs that are unable to purchase products at government-discounted rates, the company announced following FDA accelerated approval of the non-nucleoside reverse transcriptase inhibitor on April 4.